According to a recently published report by Brisk Insights, the Global Hospital Acquired Disease Testing Market is expected to grow at the CAGR of 5.9% during 2017-2025. The global hospital acquired disease testing market is segmented on the basis of infection type and geography. The report on global hospital acquired disease testing market forecast 2017-2025 (by infection type and geography) provides a detailed overview and predictive analysis of the market.
Full report available on Global Hospital Acquired Disease Testing market: Global Industry Size, Growth, Share and Forecast to 2025 report at http://www.briskinsights.com/report/hospital-acquired-disease-testing-market
Market Insights
Hospital infection also known as nosocomial infection, is the infection acquired by patient during the stay in hospital, which was previously not observed. The infection is acquired due to immune compromised patient, prolonged stay in hospital, hospital or staff negligence in carrying out procedure or maintaining the hygiene. According to a survey 9.2 patients from 100 in the U.S. suffer from hospital infection. Nowadays, nosocomial infection is commonly observed which is adding up to the burden of mortality and morbidity of hospital and increase in cost pressure. Thus stringent regulation and guidelines are coming up with respect to hospital hygiene and standard protocol to be followed, which acts main driver for the nosocomial infection market.
Scope of the report
1. Global Hospital Acquired Disease Testing Market, by Infection Type, 2015–2025 ($ Million)
1.1. Pneumonia
1.2. Urinary Tract Infection
1.3. Blood Stream Infection
1.4. Surgical Site Infection
1.5. MRSA
1.6. Others
1.2. Urinary Tract Infection
1.3. Blood Stream Infection
1.4. Surgical Site Infection
1.5. MRSA
1.6. Others
2. Global Hospital Acquired Disease Testing Market, by Geography, 2015-2025 ($ Million)
2.1. North America (U.S. & Canada)
2.2. Europe (U.K., Germany & Rest of Europe)
2.3. Asia Pacific (China, Japan, and Rest of APAC)
2.4. Latin America (Brazil, Mexico and Rest of LATAM)
2.5. Middle East and Africa (UAE, Saudi Arabia, South Africa)
2.2. Europe (U.K., Germany & Rest of Europe)
2.3. Asia Pacific (China, Japan, and Rest of APAC)
2.4. Latin America (Brazil, Mexico and Rest of LATAM)
2.5. Middle East and Africa (UAE, Saudi Arabia, South Africa)
Full report available on Global Hospital Acquired Disease Testing market: Global Industry Size, Growth, Share and Forecast to 2025 report at http://www.briskinsights.com/report/hospital-acquired-disease-testing-market
3. Profiles
3.1. Becton Dickinson
3.2. BioMerieux
3.3. Cepheid Inc
3.4. Cantel Medical Corp.
3.5. Qiagen
3.6. Diatherix Laboratories
3.7. Roche Holding AG
3.8. Nordion Inc
3.9. Others
3.2. BioMerieux
3.3. Cepheid Inc
3.4. Cantel Medical Corp.
3.5. Qiagen
3.6. Diatherix Laboratories
3.7. Roche Holding AG
3.8. Nordion Inc
3.9. Others
About Brisk Insights:
Brisk Insights is a global market research firm. Our insightful analysis is focused on developed and emerging markets. We identify trends and forecast markets with a view to aid businesses identify market opportunities optimize strategies. Our team of 200 analysts’ provides enterprises with strategic insights. Brisk Insights works to help enterprises grow through strategic insights and actionable solutions.
For More Details:
Contact Person: Jennifer Smith
Phone: +448081890034
Address: Office 1094 109 Vernon House Friar Lane Nottingham NG1 6DQ UK
Email: sales@briskinsights.com
No comments:
Post a Comment